Showing 1 - 1 of 1
Objective: To assess the cost effectiveness of emedastine, a new antihistamine, versus levocabastine in the treatment of acute allergic conjunctivitis (AAC) in Belgium, France, Germany, The Netherlands, Norway, Portugal and Sweden. Design and setting: Randomised double-blind multicountry...
Persistent link: https://www.econbiz.de/10005448999